Reliability and validity of the Japanese version of the Self-Identified Stage of Recovery for people with long term mental illness

Departments of Psychiatric Nursing, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
International journal of mental health nursing (Impact Factor: 2.01). 06/2010; 19(3):195-202. DOI: 10.1111/j.1447-0349.2009.00656.x
Source: PubMed

ABSTRACT The Self-Identified Stage of Recovery (SISR) is a two-part scale assessing both the stage of recovery (SISR-A) and the component processes of recovery (SISR-B) for people with mental illness. This study aimed to develop a Japanese version of the SISR and to examine its reliability and validity. The Japanese versions of the SISR-A and SISR-B were developed through focus group cognitive interviews and the translation-back translation procedure. A cross-sectional questionnaire survey was conducted of 223 participants who had long term mental illness, were aged 20 years or older, and currently living in communities and inpatient ward settings; 59.2% were males and the average age was 47.6 years. The questionnaire also included the 24-item Recovery Assessment Scale, Herth Hope Index, Empowerment Scale, and Resilience Scale. Cronbach's alpha coefficient, intraclass correlation coefficient, and weighted kappas were generally fair to high, and the SISR-A and SISR-B scores were positively correlated with other relevant scales. This study supported the reliability and validity of the Japanese versions of the SISR-A and SISR-B among people with long term mental illness in Japan.

1 Follower
  • [Show abstract] [Hide abstract]
    ABSTRACT: Stigma interferes with life goals of people with mental illness. Direct-to-consumer advertising (DTCA) may impact stigmatizing attitudes. The purpose of this study is to examine the effects of psychiatric medication DTCA on the stigmatizing and affirming attitudes of the general population versus individuals self-identified with mental illness. Participants (n = 272) were randomly assigned to watch a DTCA about Cymbalta, an antidepressant, embedded in two other advertisements for non-pharmaceutical products. Participants completed measures of stigmatizing and affirming attitudes before and after viewing this DTCA. Results indicate that the Cymbalta DTCA worsened the attitudes of the general public. These participants were less likely to offer help, endorse recovery, and agree with self-determination attitudes towards people with mental illness following viewing the DTCA. The self-identified group reported less blame, less dangerousness, less social avoidance, more pity, and greater willingness to help after viewing the DTCA. Moreover, there was significant improvement in their endorsement of recovery. Results suggest that DTCAs about psychiatric medication may increase the public's stigma towards people with mental illness but reduce stigma among individuals who identify as having a mental illness. Findings are somewhat limited by selection biases and self-report. Implications for further development of DTCAs are considered.
    Community Mental Health Journal 02/2014; 50(7). DOI:10.1007/s10597-014-9698-7 · 1.03 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: OBJECTIVE The promotion of recovery is the driving philosophy underlying national, state, and local mental health systems. Although numerous recovery-oriented measures have been developed in response, the scientific assessment of recovery measures has lagged behind. The purpose of this literature review was to review the psychometric properties of the Recovery Assessment Scale (RAS), which is arguably the most commonly used measure of recovery in the published literature. Such information is critical for advancing recovery science. METHODS A thorough literature search using the search term "Recovery Assessment Scale" was conducted in August 2012, yielding a total of 222 articles published from around the world. A total of 77 articles that included psychometric data on the RAS were used in this review. RESULTS Means and standard deviations across studies were fairly consistent. Overall, the studies indicate very good results for internal consistency, test-retest reliability, and interrater reliability. A number of studies also reported consistent factor structures for the measure. The RAS was found to have positive associations with other related constructs and negative associations with constructs such as symptoms. Finally, the RAS appears to be sensitive to change over time. CONCLUSIONS The review found significant evidence to support the use of the RAS in recovery science as a means to measure recovery and to include it in mental health research.
    Psychiatric services (Washington, D.C.) 02/2014; 65(4). DOI:10.1176/ · 1.99 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Introduction Patients' expectations regarding their prognosis has been shown to affect recovery. We completed a systematic review to identify measures that assess patients' expectations of recovery. Methods Eligible studies explored the association between patients' expectations of recovery, and return to work or claim resolution. We searched electronic databases (MEDLINE and PSYCInfo) from inception to June 21, 2014, bibliographies of eligible studies, relevant systematic reviews and our personal files. Reviewers determined study eligibility and study quality, and completed data extraction. Results Of 14,509 unique citations, 46 studies were eligible with majority of the studies (n = 27; 59 %) rated as low quality, primarily due to substantial missing data and inappropriate adjustment for age, gender and illness severity in their regression models. We identified 5 measures and 41 individual items assessing recovery expectations. Three of seven (43 %) studies using a measure to assess recovery expectations reported psychometric properties, with only one reporting both reliability and construct validity. Only two measures (Expectations of Recovery Scale and the Work-related Recovery Expectations Questionnaire) were externally validated in different populations. Overall, 44 (96 %) studies found that patient recovery expectations was a significant predictor of return to work or sick leave/disability claim resolution. Conclusions Very few studies assessing recovery expectations use a psychometrically valid measure. Current evidence suggests that patients with lower recovery expectations are less likely to resolve their disability claim or return to work versus patients with higher recovery expectations. Further validation of existing measures for assessing patient recovery expectations, or development of a new measure that addresses the limitations of existing ones, is required.
    Journal of Occupational Rehabilitation 08/2014; 25(1). DOI:10.1007/s10926-014-9535-4 · 2.80 Impact Factor